Porter Health
Genetic Testing for Cardiovascular Disease
A Comprehensive Guide to Understanding Your Genetic Risk and Testing Options
Genetic testing has revolutionized how we understand, diagnose, and prevent cardiovascular disease. With the rapidly decreasing cost of genetic testing and expanding clinical applications, genomic medicine is becoming an increasingly important tool in personalized heart disease prevention and treatment.
What Genetic Testing Can Tell You:
The Power of Early Detection:
Genetic testing can identify heart disease risk decades before symptoms appear, allowing for early interventions that can prevent heart attacks, stroke, and sudden cardiac death. For many genetic conditions, early treatment can normalize life expectancy.
Wondering if genetic testing is right for you? Your Porter Health coach can help you understand:
Schedule a consultation with your coach to discuss whether genetic testing may benefit you and your family.
Different types of genetic tests serve different purposes in cardiovascular care:
Single-Gene (Monogenic) Testing
Tests for specific genetic mutations in one gene known to cause a particular condition.
Common Examples:
Familial Hypercholesterolemia (FH): LDLR, APOB, PCSK9 genes
Hypertrophic Cardiomyopathy (HCM): MYH7, MYBPC3, and others
Long QT Syndrome: KCNQ1, KCNH2, SCN5A genes
Marfan Syndrome: FBN1 gene (aortic disease risk)
Best for: Diagnosing suspected inherited conditions based on family history or clinical findings
Multi-Gene Panel Testing
Tests multiple genes simultaneously. Cardiovascular panels may test 50-200+ genes associated with heart disease.
Panel Types:
Cardiomyopathy Panel: Tests genes for dilated, hypertrophic, and arrhythmogenic cardiomyopathy
Arrhythmia Panel: Long QT, Brugada, catecholaminergic polymorphic VT
Lipid Disorder Panel: FH and other cholesterol metabolism disorders
Aortopathy Panel: Genes associated with aortic aneurysm and dissection
Best for: When symptoms or family history suggest a genetic condition but the specific gene is unknown
Whole Exome/Genome Sequencing
Sequences all protein-coding genes (exome) or your entire genetic code (genome).
Advantages: Most comprehensive, can identify ultra-rare genetic variants and diagnose conditions that wouldn't be detected by panel testing
Considerations: Higher chance of finding "variants of uncertain significance" (VUS) - genetic changes where the medical significance is unclear
Best for: Complex cases where panel testing was negative, research studies, comprehensive risk assessment
Coming Soon: Porter Health plans to offer comprehensive Polygenic Risk Score (PRS) testing through Mass General Brigham's Personalized Medicine program. This advanced genetic test estimates your inherited risk across 8 major cardiovascular and metabolic conditions:
What is a Polygenic Risk Score?
Unlike single-gene tests that look for rare disease-causing mutations, PRS analyzes millions of common genetic variants across your genome. Each variant has a small effect on risk, but together they provide a powerful prediction of your inherited susceptibility to disease.
Clinical Impact: PRS testing can identify individuals at 2-4 times higher risk than average, even before traditional risk factors appear. This enables earlier, more aggressive preventive interventions.
Test Timeline: Results typically available in 3-4 weeks after sample collection. Your Porter Health coach will help you understand your results and create a personalized prevention plan.
Learn more: Mass General Brigham Polygenic Risk Testing
Coming Soon: Porter Health also plans to offer specialized CAD polygenic risk scoring through Allelica, a leader in precision cardiovascular genomics.
Why CAD-Specific PRS Matters:
Coronary artery disease (CAD) is the #1 killer globally. Allelica's CAD PRS uses advanced algorithms trained on diverse populations to predict your lifetime risk of:
How It Informs Your Care:
High PRS (Top 20%)
May benefit from statin therapy at younger age, coronary calcium scoring by age 40, intensive lifestyle modification
Intermediate PRS (20-80%)
Standard prevention strategies based on traditional risk factors, regular monitoring
Low PRS (Bottom 20%)
Lower than average genetic risk, but lifestyle factors still matter - don't become complacent
Test Timeline: Results typically available in 6-8 weeks. Allelica's sophisticated multi-ancestry algorithm ensures accuracy across diverse ethnic backgrounds.
Learn more: Allelica CAD Polygenic Risk Score
Genetic testing is recommended for individuals who meet certain clinical criteria. Talk to your Porter Health coach or physician if you have any of the following:
Personal History Indicators
Family History Indicators
Preventive/Risk Assessment
Important: Even if you don't meet these criteria, you may still benefit from polygenic risk scoring (PRS) to better understand your cumulative genetic risk across multiple conditions. Discuss with your Porter Health coach.
Pharmacogenomics tests how your genes affect your response to medications. This can help your doctor choose the right drug and dose for you, avoiding ineffective treatments and serious side effects.
Cardiovascular Medications with Genetic Guidance:
Clopidogrel (Plavix) - CYP2C19 Gene
Some people carry genetic variants that make clopidogrel less effective at preventing blood clots after stent placement. Testing can identify "poor metabolizers" who need alternative antiplatelet therapy (ticagrelor or prasugrel).
Warfarin (Coumadin) - CYP2C9, VKORC1 Genes
Genetic variants affect how quickly you metabolize warfarin and how sensitive you are to its blood-thinning effects. Testing helps determine the safest starting dose.
Statins - SLCO1B1 Gene
Variants in SLCO1B1 increase risk of statin-related muscle pain (myopathy). Testing can guide statin selection and dosing to minimize side effects while maintaining cholesterol-lowering benefit.
Beta-Blockers - CYP2D6, ADRB1 Genes
Genetic variants affect metabolism of certain beta-blockers (metoprolol, carvedilol) and receptor response, potentially influencing drug selection for heart failure or arrhythmia treatment.
Preemptive Pharmacogenomic Testing:
Many health systems now offer preemptive testing - you get tested once, and the results are stored in your medical record for use whenever you need a new medication throughout your lifetime.
This is especially valuable if you're planning cardiac procedures (like stent placement) or are likely to need multiple cardiovascular medications.
Pre-Test Consultation
Meet with your Porter Health coach or a genetic counselor to review your medical and family history, discuss what the test can and cannot tell you, and address concerns about privacy and insurance.
Sample Collection
Simple blood draw or saliva sample. Most tests use blood collected in a standard tube (similar to cholesterol testing) or a saliva kit that can be done at home.
Your DNA doesn't change, so you typically only need to be tested once in your lifetime.
Laboratory Analysis
The lab sequences the relevant genes or analyzes genetic variants. This is where the actual genetic testing happens.
Timeline:
- • Single-gene or panel testing: 2-4 weeks
- • Polygenic risk scores (Mass General Brigham): 3-4 weeks
- • Polygenic risk scores (Allelica CAD): 6-8 weeks
- • Whole exome/genome: 8-12 weeks
Results & Interpretation
A genetic counselor or your Porter Health team reviews your results with you, explaining what they mean for your health and what actions to take.
Possible Results:
Positive (Pathogenic Variant Found)
You carry a genetic mutation known to cause disease. Requires medical action and family screening.
Variant of Uncertain Significance (VUS)
A genetic change was found, but its medical significance is unclear. May require monitoring and re-evaluation as science advances.
Negative (No Mutation Found)
No pathogenic variants detected in genes tested. Doesn't eliminate all genetic risk, but provides reassurance.
Medical Management & Family Screening
If a pathogenic variant is found, your care team creates a personalized treatment plan. First-degree relatives should be offered cascade testing (they have a 50% chance of inheriting the same mutation).
GINA Protections (Genetic Information Nondiscrimination Act)
Federal law since 2008 that protects Americans from genetic discrimination in two important areas:
Health Insurance
Health insurers cannot use genetic information to deny coverage, raise premiums, or make enrollment decisions. They cannot request or require genetic testing.
Employment
Employers cannot use genetic information in hiring, firing, promotion, or job placement decisions. They cannot request genetic testing.
GINA Limitations - Important Gaps
GINA does NOT protect against genetic discrimination in:
Some states have additional protections. Check your state's genetic privacy laws.
Insurance Coverage for Genetic Testing
Most health insurance plans cover genetic testing when it meets medical necessity criteria:
Medicare: Covers genetic testing for cancer and certain cardiovascular conditions when ordered by a physician and deemed medically necessary.
Private Insurance: Typically covers testing when clinical criteria are met (e.g., LDL ≥190, personal/family history of genetic condition). Prior authorization may be required.
Out-of-Pocket Costs: If insurance doesn't cover testing, costs range from $100-$2,000 depending on test type. Many labs offer financial assistance programs.
Pro Tip: Before testing, your Porter Health coach can help verify insurance coverage and explore financial assistance options. Some labs offer cash-pay prices that are lower than insurance co-pays.
Genetic testing can identify inherited heart disease risk decades before symptoms appear
Multiple types of testing exist: single-gene, panels, whole genome, polygenic risk scores, and pharmacogenomics
Porter Health will offer comprehensive PRS through Mass General Brigham (8 conditions) and Allelica (CAD-specific)
Testing is recommended for those with personal/family history, very high cholesterol, or unexplained cardiac events
Polygenic risk scores can identify 2-4x higher risk even without traditional risk factors
Pharmacogenomic testing personalizes medication selection and dosing
Test results typically take 3-8 weeks depending on test type
GINA protects against genetic discrimination in health insurance and employment
GINA does NOT cover life, disability, or long-term care insurance
Early detection through genetic testing enables preventive treatment that can normalize life expectancy
If you test positive, cascade screening for family members can save lives
Your Porter Health coach can help determine if genetic testing is right for you
References:
Landstrom AP, Ferguson JF, James CA, et al. Genetic and Genomic Testing in Cardiovascular Disease: A Policy Statement From the American Heart Association. Circulation. 2025;152:e474-e489. doi:10.1161/CIR.0000000000001385
Musunuru K, Hershberger RE, Day SM, et al. Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association. Circ Genom Precis Med. 2020;13:e000067. doi:10.1161/HCG.0000000000000067
O'Sullivan JW, Raghavan S, Marquez-Luna C, et al. Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2022;146:e93-e118. doi:10.1161/CIR.0000000000001077
Patel AP, Wang M, Ruan Y, et al. A Multi-Ancestry Polygenic Risk Score Improves Risk Prediction for Coronary Artery Disease. Nat Med. 2023;29:1793-1803. doi:10.1038/s41591-023-02429-x
Mass General Brigham Personalized Medicine: Polygenic Risk Testing. Accessed February 2026. https://www.massgeneralbrigham.org/en/research-and-innovation/centers-and-programs/personalized-medicine/molecular-medicine/tests/polygenic-risk
Allelica: Polygenic Risk Score Test for Coronary Artery Disease. Accessed February 2026. https://allelica.com/prs-test/page-2.html
Schunkert H, Natarajan P, Samani NJ. The Inherited Basis of Coronary Artery Disease. N Engl J Med. 2026;394:576-587. doi:10.1056/NEJMra2405153